Arsenic
methylation, the primary biotransformation in the human
body, is catalyzed by the enzyme As(III) S-adenosylmethionine (SAM)
methyltransferases (hAS3MT). This process is thought to be protective
from acute high-level arsenic exposure. However, with long-term low-level
exposure, hAS3MT produces intracellular methylarsenite (MAs(III))
and dimethylarsenite (DMAs(III)), which are considerably more toxic
than inorganic As(III) and may contribute to arsenic-related diseases.
Several single nucleotide polymorphisms (SNPs) in putative regulatory
elements of the hAS3MT gene have been shown to be protective. In contrast,
three previously identified exonic SNPs (R173W, M287T, and T306I)
may be deleterious. The goal of this study was to examine the effect
of single amino acid substitutions in hAS3MT on the activity of the
enzyme that might explain their contributions to adverse health effects
of environmental arsenic. We identified five additional intragenic
variants in hAS3MT (H51R, C61W, I136T, W203C, and R251H). We purified
the eight polymorphic hAS3MT proteins and characterized their enzymatic
properties. Each enzyme had low methylation activity through decreased
affinity for substrate, lower overall rates of catalysis, or lower
stability. We propose that amino acid substitutions in hAS3MT with
decreased catalytic activity lead to detrimental responses to environmental
arsenic and may increase the risk of arsenic-related diseases.